CBA, CSL, ResMed too expensive, says Maple Brown
Price falls for CSL, ResMed and Macquarie show that following the herd to buy defensive businesses may produce suboptimal returns if you pay too much.
Source: afr.com
Stay updated with breaking news from Lazard Select. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Price falls for CSL, ResMed and Macquarie show that following the herd to buy defensive businesses may produce suboptimal returns if you pay too much.